Breaking News Instant updates and real-time market news.

MRK

Merck

$62.80

0.34 (0.54%)

07:06
10/06/16
10/06
07:06
10/06/16
07:06

Merck's posaconazole gets orphan status in treatment of invasive aspergillosis

Merck's posaconazole was designated for orphan status by the FDA as a treatment of invasive aspergillosis, according to a post to the agency's website. Reference Link

  • 07

    Oct

  • 25

    Oct

  • 06

    Nov

MRK Merck
$62.80

0.34 (0.54%)

08/19/16
UBSW
08/19/16
NO CHANGE
Target $70
UBSW
Buy
Merck price target raised to $70 from $62 at UBS
UBS analyst Marc Goodman raised his price target on Merck (MRK) to $70 from $62 as he updated his model to account for a more favorable Keytruda opportunity following the failed CheckMate-026 trial at Bristol-Myers (BMY). The analyst also feels investors do not give enough credit to Merck's Januvia franchise or the potential for growth opportunity from the pipeline. Goodman reiterated his Buy rating on Merck shares.
09/21/16
FBCO
09/21/16
UPGRADE
Target $41
FBCO
Outperform
Clovis upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Kennen MacKay upgraded Clovis Oncology (CLVS) to Outperform and raised his price target for the shares to $41 from $19. Clovis closed yesterday up 13%, or $3.92, to $34.83. The potential for a takeover "outweighs concerns surrounding patent life, limited experience in platinum resistant/refractory patients, and PARPi competition," MacKay tells investors in a research note. Clovis could be worth $35-$41 per share in a buyout on operational synergies, and $52-$55 per share with leveraged tax benefits, MacKay estimates. He points out that Eli Lilly (Lill)y, Merck (MRK), Japan's Takeda and others have expressed interest in acquiring U.S. oncology companies.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
10/03/16
LEER
10/03/16
NO CHANGE
LEER
Market Perform
AASLD abstracts hint at potential competitive threat to Gilead HCV, says Leerink
Leerink analyst Geoffrey Porges says abstracts for the American Association for the Study of Liver Diseases, or AASLD, meeting revealed very limited efficacy information about the new Hepatitis C regimens for Gilead (GILD), Merck (MRK) and AbbVie (ABBV). Nonetheless, the analyst believes the abstracts hint at the potential competitive threat to Gilead's HCV dominance. While the new 12-week HCV regimens may compete on price, the forthcoming 8-week regimens put the most pressure on Gilead's market share, Porges argues. He reiterates a Market Perform rating on Gilead's shares.

TODAY'S FREE FLY STORIES

CAT

Caterpillar

$96.72

-1.48 (-1.51%)

11:10
02/23/17
02/23
11:10
02/23/17
11:10
Hot Stocks
Trump calls Caterpillar 'great company,' speaks of level playing field »

President Trump, during a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 28

    Feb

  • 07

    Mar

  • 07

    Mar

  • 14

    Jun

11:10
02/23/17
02/23
11:10
02/23/17
11:10
Hot Stocks
Breaking Hot Stocks news story  »

TrovaGene trading halted,…

11:10
02/23/17
02/23
11:10
02/23/17
11:10
General news
Bull widening in the Bund/T-note spread »

Bull widening in the…

BA

Boeing

$176.59

1.2274 (0.70%)

11:05
02/23/17
02/23
11:05
02/23/17
11:05
Hot Stocks
Boeing reports 31 new orders in weekly update »

Boeing, on its website,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
52-Week Bill Announcement CUSIP Number data reported »

52-Week Bill Announcement…

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
52-Week Bill Announcement Offering Amount data reported »

52-Week Bill Announcement…

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
6-Month Bill Announcement CUSIP Number data reported »

6-Month Bill Announcement…

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

FRTA

Forterra

$18.52

-0.14 (-0.75%)

11:04
02/23/17
02/23
11:04
02/23/17
11:04
Conference/Events
Forterra management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 30

    Mar

LMT

Lockheed Martin

$263.90

-2.025 (-0.76%)

11:03
02/23/17
02/23
11:03
02/23/17
11:03
Hot Stocks
Trump says Lockheed Martin cut plane costs by $700M »

President Trump, during a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LHCG

LHC Group

$49.26

0.36 (0.74%)

11:02
02/23/17
02/23
11:02
02/23/17
11:02
Conference/Events
LHC Group management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 09

    Mar

  • 21

    Mar

NTT

Nippon Telegraph

$42.17

0.22 (0.52%)

11:02
02/23/17
02/23
11:02
02/23/17
11:02
Hot Stocks
NTT Communication to acquire 100% ownership of RagingWire Data Centers »

RagingWire Data Centers,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLSE

Pulse Biosciences

$14.49

0.66 (4.77%)

11:01
02/23/17
02/23
11:01
02/23/17
11:01
Periodicals
Pulse Biosciences mentioned cautiously by TheStreetSweeper 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
02/23/17
02/23
11:01
02/23/17
11:01
General news
Kansas City Fed Manufacturing Index Level data reported »

February Kansas City Fed…

NLSN

Nielsen

$45.10

0.215 (0.48%)

11:01
02/23/17
02/23
11:01
02/23/17
11:01
Hot Stocks
Nielsen says Univision signs multiyear agreement with Nielsen Audio »

Nielsen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

FEYE

FireEye

$11.23

-0.57 (-4.83%)

11:01
02/23/17
02/23
11:01
02/23/17
11:01
Options
Call buyers jump as FireEye shares catch fire »

Call buyers jump as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

11:00
02/23/17
02/23
11:00
02/23/17
11:00
General news
EIA crude inventories for week of February 17 »

Crude oil inventories…

11:00
02/23/17
02/23
11:00
02/23/17
11:00
General news
Treasury 7-year auction outlook: »

Treasury 7-year auction…

10:55
02/23/17
02/23
10:55
02/23/17
10:55
General news
U.S. tax refunds »

U.S. tax refunds are…

ORCL

Oracle

$42.84

0.33 (0.78%)

10:51
02/23/17
02/23
10:51
02/23/17
10:51
Options
Large option block opened in Oracle as shares reach 52-week highs »

Large option block opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
02/23/17
02/23
10:50
02/23/17
10:50
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

NVDA

NVIDIA

$110.76

-0.31 (-0.28%)

, INTC

Intel

$36.07

-0.45 (-1.23%)

10:50
02/23/17
02/23
10:50
02/23/17
10:50
Hot Stocks
Analysts say sell NVIDIA amid competitive changes, gaming slowdown »

Shares of NVIDIA (NVDA)…

NVDA

NVIDIA

$110.76

-0.31 (-0.28%)

INTC

Intel

$36.07

-0.45 (-1.23%)

AMD

AMD

$14.28

0.28 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 27

    Feb

  • 05

    Mar

  • 16

    Mar

  • 19

    Mar

  • 04

    Apr

  • 05

    Apr

AMCX

AMC Networks

$57.50

-0.19 (-0.33%)

10:46
02/23/17
02/23
10:46
02/23/17
10:46
Hot Stocks
AMC Networks sees Q1 as most challenging time for AOI comps »

On the call, the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

FCX

Freeport McMoRan

$13.77

0.0354 (0.26%)

10:46
02/23/17
02/23
10:46
02/23/17
10:46
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HD

Home Depot

$145.90

0.65 (0.45%)

, LOW

Lowe's

$76.75

-0.055 (-0.07%)

10:45
02/23/17
02/23
10:45
02/23/17
10:45
Hot Stocks
Analyst says buy Home Depot as market underestimates housing recovery »

Morgan Stanley upgraded…

HD

Home Depot

$145.90

0.65 (0.45%)

LOW

Lowe's

$76.75

-0.055 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

  • 15

    Mar

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.